Video Experimental Relacionado
Updated: Mar 3, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.8K
Cáncer de campo impulsado por inflamación en la enfermedad renal terminal
Rebecca A Sager1, Katalin Susztak2,3, A Ari Hakimi1,4
1Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer discovery
|March 2, 2026
Resumen
La enfermedad renal quística adquirida y el carcinoma de células renales asociado surgen de células del túbulo proximal expandidas dentro de un entorno inflamatorio. Este estudio ofrece información sobre el desarrollo de quistes renales y los orígenes del cáncer en pacientes con enfermedad renal terminal.
Área de la Ciencia:
- Oncología
- Nefrología
- Genómica
Sus antecedentes:
- La enfermedad renal terminal (ERCT) está relacionada con la enfermedad renal quística adquirida (ERQA).
- La ERQA puede progresar a carcinoma de células renales asociado a enfermedad quística adquirida (ACD-RCC).
- Los orígenes celulares y los impulsores moleculares de la ERQA y el ACD-RCC siguen sin comprenderse completamente.
Objetivo del estudio:
- Analizar de manera integral las características genómicas, transcriptómicas y espaciales del carcinoma de células renales asociado a la ERQA.
- Elucidar los orígenes celulares y las vías de desarrollo de la ERQA y el carcinoma de células renales asociado a la ERQA.
- Identificar los factores moleculares y del microambiente clave que impulsan la patogénesis de la ERQA y el carcinoma de células renales asociado a la ERQA.
Principales métodos:
- Análisis multiómico que incluye genómica, transcriptómica y transcriptómica espacial.
- Análisis comparativo de tejido renal normal, quistes de ERQA y ACD-RCC.
- Rastreo de linaje celular y caracterización del microambiente.
Principales resultados:
- Demostró la expansión clonal de un subconjunto específico de células del túbulo proximal.
- Identificó un microambiente proinflamatorio que apoya el desarrollo de quistes y tumores.
- Reveló firmas moleculares distintas que diferencian los quistes de la ERQA del carcinoma de células renales asociado a la ERQA.
Conclusiones:
- Los quistes de ERQA y el ACD-RCC se originan a partir de una población común de células progenitoras.
- Un microambiente inflamatorio es crucial para el desarrollo tanto de la ERQA como del ACD-RCC.
- Estos hallazgos proporcionan un marco para comprender la cistogénesis y la tumorigénesis renal en la ERCT.
Palabras clave:
Enfermedad renal quística adquiridaCarcinoma de células renales asociado a quistesEnfermedad renal terminalCélulas del túbulo proximalMicroambiente inflamatorioOncologíaNefrologíaGenómicaMás Videos Relacionados
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
14.3K
06:29Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
Published on: January 31, 2025
1.3K
Videos de Conceptos Relacionados
01:25Chronic Kidney Disease I: Introduction
872
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
872
01:24Chronic Kidney Disease II: Clinical Manifestations
807
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
807
01:28Chronic Kidney Disease III: Interprofessional Care
539
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
539
01:29Acute Kidney Injury II: Pathophysiology
1.4K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.4K
01:28Kidney Transplant I: Introduction
599
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
599
01:29Acute Kidney Injury III: Clinical Manifestations
1.1K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.1K